Publications

5808 Results

Phase III trial of doxorubicin (A) vs paclitaxel (T) vs doxorubicin + paclitaxel (A+T) as first-line therapy for metastatic breast cancer (MBC): an Intergroup trial.

Authors
GW Sledge Jr;D Neuberg;J Ingle;S Martino;W Wood
Journal / Conference
Proc of the American Society of Clinical Oncology 16:1a(#2)
Year
1997
Research Committee(s)
Breast

Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study.

Authors
JK Benedetti;HA Burris III;SP Balcerzak;JS Macdonald
Journal / Conference
Investigational New Drugs 15(3):261-264
Year
1997
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9150

Phase II trial of topotecan in hepatocellular carcinoma. A Southwest Oncology Group study.

Authors
JG Wall;JK Benedetti;MA O'Rourke;RB Natale;JS Macdonald
Journal / Conference
Investigational New Drugs 15(3):257-260
Year
1997
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9151

A phase 2 Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma.

Authors
ML Keohan;MR Grever;SP Balcerzak;K Antman
Journal / Conference
Investigational New Drugs 15:255-256
Year
1997
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8370

Aneusomy detection by fluorescence in situ hybridization (FISH) using bladder washings: Correlation with cytology, cytogenetics and clinical features predicts recurrence and defines test limitations

Authors
ML Slovak;F Zhang;T Wilson;MH Kawachi;DA Arber;TS McConnell;SM Dobin
Journal / Conference
Proc Seventh International Workshop on Chromosomes in Solid Tumors #20:
Year
1997
Research Committee(s)
Genitourinary

Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the Southwest Oncology Group.

Authors
FR Appelbaum;KJ Kopecky
Journal / Conference
Cancer 80:2199-2204
Year
1997
Research Committee(s)
Leukemia
Study Number(s)
SWOG-7823/24/25/26, SWOG-8124/25/26, SWOG-8600

Treatment of in-transit melanoma metastases with tumour necrosis factor (TNF-a) and chemotherapy administered in isolated limb perfusion (ILP).

Authors
F Lejeune;D Lienard;H Schraffordt Koops;B Kroon;A Eggermont
Journal / Conference
4th World Conference on Melanoma- Sydney Australia 7(Suppl.1):848(#167)
Year
1997
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8593 (INT-0065)

High dose cisplatin (C) and continuous infusion 5 fluorouracil (5FU CI) for the treatment of advanced/recurrent transitional cell cancer of the bladder (ARTCCB). Final report of a Southwest Oncology Group (SWOG) trial.

Authors
J Kish;M Wolf;P Schellhammer;M Hussain;A Einstein;E Crawford
Journal / Conference
Proc Seventh International Congress on Anti-Cancer Treatment #254:
Year
1997
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8956

All-trans-retinoic acid in acute promyelocytic leukemia.

Authors
MS Tallman;JW Andersen;CA Schiffer;FR Appelbaum;JH Feusner;A Ogden;L Shepherd;CL Willman;CD Bloomfield;JM Rowe;PH Wiernik
Journal / Conference
New England Journal of Medicine 337:1021-1028
Year
1997
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Ocnology Group trial (SWOG-9241).

Authors
JS Macdonald;JK Benedetti;M Modiano;DS Alberts
Journal / Conference
Investigational New Drugs 15:357-359
Year
1997
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9241